School of Nursing & Midwifery, Monash University (Peninsula Campus), Australia.
J Adv Nurs. 2012 Nov;68(11):2515-25. doi: 10.1111/j.1365-2648.2012.05950.x. Epub 2012 Feb 15.
The aim of this study was to test the feasibility and impact of an intervention consisting of self-monitored blood pressure, medicine review, a Digital Versatile Disc, and motivational interviewing telephone calls to help people with diabetes and kidney disease improve their blood pressure control and adherence to prescribed medications.
People with co-existing diabetes, kidney disease and hypertension require multiple medications to manage their health. About 50% of people are non-adherent to their prescribed medications with non-adherence increasing in the presence of chronic conditions.
Randomized controlled trial.
Patients aged ≥18 years with diabetes, chronic kidney disease and systolic hypertension were recruited from nephrology and diabetes outpatients' clinics of an Australian metropolitan hospital between 2008-2009. Participants were randomly allocated on a 1:1 basis to one of two groups in a randomized controlled trial: the intervention delivered over 3 months (n = 39) and usual care (n = 41), with follow-up at 3, 6 and 9 months postintervention. People collecting data and assessing outcomes were blinded to group assignment.
Seventy-five participants completed the study. The intervention was acceptable and feasible for this cohort. There were no statistically significant differences between groups, although the mean systolic blood pressure reduction in the intervention group (n = 36) was -6·9 mmHg 95% CI (-13·8, -0·02) at 9 months postintervention.
The study was feasible and statistically significant differences may be determinable in a larger sample to overcome the variability between groups, paying attention to recommendations for further research.
The trial was prospectively registered with the Australian and New Zealand Clinical Trials Register (ACTRN12607000044426).
本研究旨在测试一项干预措施的可行性和效果,该措施包括自我监测血压、药物审查、数字多功能光盘和动机访谈电话,以帮助患有糖尿病和肾病的患者改善血压控制和遵医嘱服药情况。
同时患有糖尿病、肾病和高血压的患者需要服用多种药物来管理他们的健康。大约有 50%的人不遵医嘱服药,而在存在慢性疾病的情况下,不遵医嘱服药的情况会增加。
随机对照试验。
2008-2009 年,从澳大利亚一家大都市医院的肾病和糖尿病门诊招募了年龄≥18 岁、患有糖尿病、慢性肾病和收缩期高血压的患者。参与者以 1:1 的比例随机分配到 3 个月的干预组(n=39)和常规护理组(n=41),在干预后 3、6 和 9 个月进行随访。收集数据和评估结果的人员对分组情况不知情。
75 名参与者完成了研究。该干预措施对该队列是可接受且可行的。虽然干预组(n=36)的收缩压降低均值在 9 个月时为-6.9mmHg(95%CI:-13.8,-0.02),但两组间无统计学显著差异。
该研究是可行的,在更大的样本量中可能会确定出统计学显著差异,以克服组间的变异性,同时注意为进一步研究提出的建议。
该试验前瞻性地在澳大利亚和新西兰临床试验注册中心(ACTRN12607000044426)注册。